{
    "Symbol": "CTLT",
    "AssetType": "Common Stock",
    "Name": "Catalent Inc",
    "Description": "Catalent, Inc. (Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products.",
    "CIK": "1596783",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "14 SCHOOLHOUSE ROAD, SOMERSET, NJ, US",
    "FiscalYearEnd": "June",
    "LatestQuarter": "2022-12-31",
    "MarketCapitalization": "12370383000",
    "EBITDA": "1101000000",
    "PERatio": "30.53",
    "PEGRatio": "1.177",
    "BookValue": "27.29",
    "DividendPerShare": "0",
    "DividendYield": "0",
    "EPS": "2.25",
    "RevenuePerShareTTM": "26.5",
    "ProfitMargin": "0.0862",
    "OperatingMarginTTM": "0.147",
    "ReturnOnAssetsTTM": "0.041",
    "ReturnOnEquityTTM": "0.0873",
    "RevenueTTM": "4757000000",
    "GrossProfitTTM": "1640000000",
    "DilutedEPSTTM": "2.25",
    "QuarterlyEarningsGrowthYOY": "-0.154",
    "QuarterlyRevenueGrowthYOY": "-0.056",
    "AnalystTargetPrice": "78.92",
    "TrailingPE": "30.53",
    "ForwardPE": "13.19",
    "PriceToSalesRatioTTM": "1.65",
    "PriceToBookRatio": "1.771",
    "EVToRevenue": "2.528",
    "EVToEBITDA": "11.84",
    "Beta": "1.262",
    "52WeekHigh": "115.33",
    "52WeekLow": "40.69",
    "50DayMovingAverage": "54.64",
    "200DayMovingAverage": "78.1",
    "SharesOutstanding": "180090000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}